Clinical Trial Update: Open Label Immunotherapy Trial for Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 open-label immunotherapy trial for ovarian cancer is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Immunitor LLC | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN